These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2508776)

  • 1. In vitro fertilization and embryo transfer in the rhesus monkey.
    Wolf DP; Vandevoort CA; Meyer-Haas GR; Zelinski-Wooten MB; Hess DL; Baughman WL; Stouffer RL
    Biol Reprod; 1989 Aug; 41(2):335-46. PubMed ID: 2508776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
    VandeVoort CA; Hess DL; Stouffer RL
    Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity at collection and the developmental potential of rhesus monkey oocytes.
    Lanzendorf SE; Zelinski-Wooten MB; Stouffer RL; Wolf DP
    Biol Reprod; 1990 Apr; 42(4):703-11. PubMed ID: 2189504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys.
    Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
    Fertil Steril; 1994 Jun; 61(6):1147-55. PubMed ID: 8194632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge.
    Chandrasekher YA; Hutchison JS; Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1994 Jul; 79(1):298-306. PubMed ID: 8027245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different regimens of human gonadotropins for superovulation of rhesus monkeys: ovulatory response and subsequent luteal function.
    Vandevoort CA; Baughman WL; Stouffer RL
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):85-91. PubMed ID: 2498448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes.
    Suikkari AM; Tulppala M; Tuuri T; Hovatta O; Barnes F
    Hum Reprod; 2000 Apr; 15(4):747-51. PubMed ID: 10739813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth of rhesus monkey infant after in vitro fertilization and nonsurgical embryo transfer.
    Bavister BD; Boatman DE; Collins K; Dierschke DJ; Eisele SG
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2218-22. PubMed ID: 6326113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-sensitive progesterone production by rhesus monkey luteal cells in vitro: a function of age of the corpus luteum during the menstrual cycle.
    Stouffer RL; Nixon WE; Gulyas BJ; Hodgen GD
    Endocrinology; 1977 Feb; 100(2):506-12. PubMed ID: 401732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus monkey oocyte maturation and fertilization in vitro: roles of the menstrual cycle phase and of exogenous gonadotropins.
    Alak BM; Wolf DP
    Biol Reprod; 1994 Nov; 51(5):879-87. PubMed ID: 7849190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone.
    Weston AM; Zelinski-Wooten MB; Hutchison JS; Stouffer RL; Wolf DP
    Hum Reprod; 1996 Mar; 11(3):608-13. PubMed ID: 8671277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
    Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.